Ascom deploys software solution Digistat for Italian Campus Bio-Medico University Hospital

Jul 11, 2019

Ascom wins a contract to deliver the Ascom Healthcare Platform and its software solution Digistat for ICUs, surgical rooms and labs in the renowned Campus Bio-Medico University Hospital in Rome. The value of the order exceeds half a million Swiss francs.

The Campus Bio-Medico University Hospital (www.policlinicocampusbiomedico.it) aims to optimize its clinical workflows with the Ascom Healthcare Platform and its integrated Digistat software solution for Intensive Care Units (ICU) and operating rooms as well as hemodynamic and endoscopy labs. After going through a thorough evaluation and by establishing a close collaboration with the hospital, Ascom has worked out the most attractive solution.

Ascom will be the provider for the Italian university hospital, an international center of excellence that is accredited by the Joint Commission International (JCI) since 2014. JCI is an organization that identifies, measures, and shares best practices in quality and patient safety. The accreditation indicates very high levels of efficiency and security in patient treatment.

Francis Schmeer, Chief Sales and Marketing Officer of Ascom, says: "This order is another success in selling our Ascom Healthcare Platform and its software solution Digistat to a major customer in the European healthcare sector. The win shows that Ascom is a real solutions provider with a profound knowledge base in improving clinical workflows in a state-of-the-art fashion."

This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).